[go: up one dir, main page]

PL3374024T3 - Sposób i zestaw do leczenia nowotworu mózgu za pomocą systemu ultradźwiękowego - Google Patents

Sposób i zestaw do leczenia nowotworu mózgu za pomocą systemu ultradźwiękowego

Info

Publication number
PL3374024T3
PL3374024T3 PL16863657.9T PL16863657T PL3374024T3 PL 3374024 T3 PL3374024 T3 PL 3374024T3 PL 16863657 T PL16863657 T PL 16863657T PL 3374024 T3 PL3374024 T3 PL 3374024T3
Authority
PL
Poland
Prior art keywords
kit
brain tumor
ultrasound system
treating brain
treating
Prior art date
Application number
PL16863657.9T
Other languages
English (en)
Inventor
Hao-Li Liu
Po-Chun Chu
Ting-Kuang CHANG
Kuo-Chen Wei
Pin-Yuan Chen
Chiung-Yin Huang
Original Assignee
Navifus Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Navifus Co., Ltd. filed Critical Navifus Co., Ltd.
Publication of PL3374024T3 publication Critical patent/PL3374024T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N7/02Localised ultrasound hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0004Applications of ultrasound therapy
    • A61N2007/0021Neural system treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00Ultrasound therapy
    • A61N2007/0039Ultrasound therapy using microbubbles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
PL16863657.9T 2015-11-11 2016-11-10 Sposób i zestaw do leczenia nowotworu mózgu za pomocą systemu ultradźwiękowego PL3374024T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562253805P 2015-11-11 2015-11-11
PCT/CN2016/105293 WO2017080481A1 (en) 2015-11-11 2016-11-10 Method and kit for treating brain tumor by using ultrasound system

Publications (1)

Publication Number Publication Date
PL3374024T3 true PL3374024T3 (pl) 2022-12-12

Family

ID=58694540

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16863657.9T PL3374024T3 (pl) 2015-11-11 2016-11-10 Sposób i zestaw do leczenia nowotworu mózgu za pomocą systemu ultradźwiękowego

Country Status (11)

Country Link
US (1) US20210106849A1 (pl)
EP (1) EP3374024B1 (pl)
JP (1) JP7053463B2 (pl)
CN (1) CN108430579B (pl)
AU (1) AU2016354728B2 (pl)
DK (1) DK3374024T3 (pl)
ES (1) ES2925002T3 (pl)
HU (1) HUE059596T2 (pl)
PL (1) PL3374024T3 (pl)
TW (1) TWI751122B (pl)
WO (1) WO2017080481A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105658243B (zh) 2013-09-27 2019-11-08 菲尼克斯解决方案有限公司 超声介导的药物递送
EP3233187B1 (en) 2014-12-19 2022-06-01 Sorbonne Université Implantable ultrasound generating treating device for brain treatment
CN109414243B (zh) 2016-03-11 2022-03-29 索邦大学 用于脊髓和脊神经治疗的外部超声波生成治疗装置、包括该装置的设备和实施该装置的方法
CN109414595A (zh) 2016-03-11 2019-03-01 索邦大学 用于脊髓和/或脊神经治疗的可植入超声产生治疗装置、包括该装置的设备及方法
US20210253739A1 (en) * 2018-08-23 2021-08-19 Siwa Corporation Anticarboxymethyl lysine antibodies and ultrasound for removing age-modified cells
WO2020211076A1 (zh) * 2019-04-19 2020-10-22 深圳先进技术研究院 一种实现超声穿颅聚焦的方法以及电子设备
EP3957299A1 (en) * 2020-08-17 2022-02-23 ETH Zurich Localized delivery of diagnostic or therapeutic agents using focused ultrasound
GB2605422B (en) * 2021-03-31 2025-04-30 Act Therapeutics Ltd Treatment of the central nervous system

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5752515A (en) * 1996-08-21 1998-05-19 Brigham & Women's Hospital Methods and apparatus for image-guided ultrasound delivery of compounds through the blood-brain barrier
US7896821B1 (en) * 2003-11-14 2011-03-01 Perfusion Technology, LLC Low intensity directed ultrasound (LODUS) mediated blood brain barrier disruption
WO2006096755A2 (en) 2005-03-07 2006-09-14 The Brigham And Women's Hospital, Inc. Adaptive ultrasound delivery system
EP1986632B1 (en) * 2006-02-10 2012-08-15 Nerviano Medical Sciences S.R.L. Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
WO2007146414A2 (en) * 2006-06-15 2007-12-21 Biogen Idec Ma Inc. Combination therapy employing lymphotoxin beta receptor binding molecules in combination with second agents
US20100203048A1 (en) * 2008-04-30 2010-08-12 Stephen Evans-Freke Methods of using corticotropin-releasing factor for the use of the treatment of cancer
TWI382860B (zh) * 2008-07-11 2013-01-21 Univ Chang Gung 非侵入式低頻超音波腦部治療裝置及其使用方法
WO2010010473A1 (en) 2008-07-23 2010-01-28 Koninklijke Philips Electronics, N.V. Ultrasound mediated drug delivery
US20100143241A1 (en) * 2008-10-22 2010-06-10 Johnson G Allan Method and apparatus for delivery of agents across the blood brain barrier
WO2011101039A1 (en) * 2010-02-22 2011-08-25 Universite Pierre Et Marie Curie (Paris 6) Apparatus for the treatment of brain affections and method implementing thereof
EP2600777A1 (en) * 2010-08-05 2013-06-12 The Trustees of Columbia University in the City of New York Systems, methods, and devices for ultrasonic assessment of cancer and response to therapy
US20120095325A1 (en) 2010-10-15 2012-04-19 Chang Gung Medical Foundation, Linkou Branch Treatment of brain diseases via ultrasound/magnetic targeting delivery and tracing of therapeutic agents
GB201019434D0 (en) 2010-11-17 2010-12-29 Isis Innovation Sonosensitive nanoparticles
CN103339508A (zh) 2010-12-09 2013-10-02 霍夫曼-拉罗奇有限公司 Agtr1作为贝伐单抗联合疗法的标志物
WO2012162664A1 (en) * 2011-05-26 2012-11-29 The Trustees Of Columbia University In The City Of New York Systems and methods for opening of a tissue barrier in primates
EP2768386B1 (en) * 2011-10-19 2024-04-03 Tel HaShomer Medical Research Infrastructure and Services Ltd. Magnetic resonance maps for analyzing tissue
CN102525935A (zh) * 2012-01-18 2012-07-04 上海交通大学医学院 一种纳米药物载体脑内递送方法
US9149455B2 (en) * 2012-11-09 2015-10-06 Abraxis Bioscience, Llc Methods of treating melanoma
CN105658243B (zh) 2013-09-27 2019-11-08 菲尼克斯解决方案有限公司 超声介导的药物递送
CA2989362C (en) * 2014-06-20 2024-09-10 Univ Queensland TREATMENT OF NEURODEGENERATIVE DISEASES
WO2017004562A1 (en) * 2015-07-01 2017-01-05 The Trustees Of Columbia University In The City Of New York Systems and methods for modulation and mapping of brain tissue using an ultrasound assembly

Also Published As

Publication number Publication date
AU2016354728A1 (en) 2018-05-24
CN108430579B (zh) 2021-02-05
ES2925002T3 (es) 2022-10-13
AU2016354728B2 (en) 2019-02-28
HK1256135A1 (zh) 2019-09-13
DK3374024T3 (da) 2022-08-15
US20210106849A1 (en) 2021-04-15
TW201729866A (zh) 2017-09-01
TWI751122B (zh) 2022-01-01
EP3374024B1 (en) 2022-07-13
CN108430579A (zh) 2018-08-21
EP3374024A4 (en) 2019-06-19
JP2019502657A (ja) 2019-01-31
WO2017080481A1 (en) 2017-05-18
HUE059596T2 (hu) 2022-12-28
JP7053463B2 (ja) 2022-04-12
EP3374024A1 (en) 2018-09-19

Similar Documents

Publication Publication Date Title
IL298497B1 (en) A method for treating cancer
ZA201705673B (en) Methods for treating skin
IL250329A0 (en) System and method for optogenetic therapy
ZA201701491B (en) Methods and therapeutic combinations for treating tumors
ZA201703290B (en) Methods for tumor treatment using cd3xcd20 bispecific antibody
SG10201913409VA (en) Methods for solid tumor treatment
IL257691A (en) A method for treating cancer
HUE059596T2 (hu) Agydaganat kezelésének módszere és készlete ultrahangos rendszer segítségével
IL256836B (en) Methods for treating cancer using apilimod
IL254014A0 (en) System and method for water treatment
PT3322827T (pt) Método melhorado para curtimento de pele de animal.
ZA202001927B (en) Method for treating tnf alpha-related diseases
GB2537603B (en) Method and apparatus for water treatment
SG10201508795XA (en) Method for treating cancer
IL255012A0 (en) Preparations and methods for treating skin conditions
ZA201607027B (en) Method for treating or enhancing muscle tissue
GB2594828B (en) Method and apparatus for water treatment
EP3325125A4 (en) Method and apparatus for water treatment
HK1237665A1 (en) Methods and therapeutic combinations for treating tumors
GB201501202D0 (en) Novel methods for diagnosis and therapy
GB201507268D0 (en) Method for stimulating aerogenosis